Gardasil (HPV4) Flashcards
TYPE:
Inactive
ROUTE:
IM
INDICATION:
Girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine:
- Cancer (cervical, vulvar, vaginal, and anal) caused by HPV types 16 and 18
- Genital warts (condyloma acuminata) caused by HPV types 6 and 11
- Precancerous or dysplastic lesions (cervical, vulvar, vaginal, and anal) caused by HPV types 6, 11, 16, and 18
Boys and men 9 through 26 years of age for the prevention of the following diseases caused by HPV types included in the vaccine:
- Anal cancer caused by HPV types 16 and 18
- Genital warts (condyloma acuminata) caused by HPV types 6 and 11
- Precancerous or dysplastic lesions (anal) caused by HPV types 6, 11, 16, and 18
DOSE:
0.5 mL
OF DOSES:
3 doses
FREQUENCY:
Give at age 11–12 years on a 0, 1–2, and 6 month schedule. May be given as early as age 9 years.
For all who were not previously vaccinated, give 3‐dose series (0, 2, 6 month schedule):
- to older girls/women through age 26 years
- to older boys/men through age 21 years
Give a 3‐dose series to all previously unvaccinated men age 21‐26 years who:
- have sex with men
- are immunocompromised as a result of infection (including HIV), disease, or medications
Minimum intervals between doses:
- 4 wks between #1 and #2
- 12 wks between #2 and #3
- at least 24 wks between doses #1 and #3.
If possible, use the same vaccine product for all doses
CONTRAINDICATIONS:
Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or a previous dose of the vaccine
PRECAUTIONS:
A) Moderate or severe acute illness with or without fever
B) Pregnancy
C) Syncope ‐ because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended.
ADVERSE REACTIONS:
Injection Site: pain, swelling, erythema, pruritus, and bruising
Systemic: syncope, headache, fever, nausea, and dizziness
